Compared with pre-treatment measurements, PCOS patients treated with sitagliptin showed a significant reduction in DPP4 activity in endometrial tissue (Fig. 9A, B, and Supplementary Fig. 8, t value of DPP4 = 6.020, p = 0.0038). The gene discussed is DPP4; the disease is polycystic ovary syndrome.